Works matching IS 21641153 AND DT 2022 AND VI 12 AND IP 1
Results: 13
New Oncology Drugs/Indications and Fast-Track Designations Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 51
- Publication type:
- Article
Time-Limited Venetoclax Combinations Superior to Chemoimmunotherapy in Fit Patients with CLL.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 49
- Publication type:
- Article
Isatuximab plus RVd Regimen Achieves Highest Rates of No MRD in Patients with Multiple Myeloma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 48
- Publication type:
- Article
vosidenib Added to First-Line Azacitidine Improves Outcomes in Older Patients with AML.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 47
- Publication type:
- Article
Ivosidenib Added to First-Line Azacitidine Improves Outcomes in Older Patients with AML.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 46
- Publication type:
- Article
Polatuzumab Vedotin plus R-CHP Outperforms R-CHOP as First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 45
- Publication type:
- Article
A Paradigm Shift: CAR T-Cell Therapy Beats Standard of Care as Second-Line Treatment for Large B-Cell Lymphoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 44
- Publication type:
- Article
Immune Responses to COVID-19 Vaccines Low Among Patients with Hematologic Malignancies, but mRNA Vaccines Induce Strong Antibody Response in AML and MDS.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 43
- Publication type:
- Article
A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed and Refractory B-Cell Lymphomas.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 30
- By:
- Publication type:
- Article
Dasatinib-Induced Gynecomastia in 2 Patients with Chronic Myeloid Leukemia: Case Reports and Review of the Literature.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 24
- By:
- Publication type:
- Article
Spontaneous Tumor Lysis Syndrome in a Patient with Stage IV HER2-Positive Breast Cancer: Case Report.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 19
- By:
- Publication type:
- Article
Lidocaine plus Tetracaine-Medicated Patch Used for Propofol Sedation During Lumbar Punctures in Pediatric Patients with Blood Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 12
- By:
- Publication type:
- Article
Evaluation of the Safety and Potential Time-Savings of Subcutaneous Rituximab Administration in a Single Cancer Center.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2022, v. 12, n. 1, p. 5
- By:
- Publication type:
- Article